Prospective registry of pediatric cellular therapy patients at risk for endothelial dysfunction, sinusoidal obstruction syndrome and/or multi-organ dysfunction syndrome(POEM): pmods as a screening tool for endotheliopathies and critical care admission risk in pediatric HCT patients.
Conferences
Alqahtani, S; Abdel-Azim, H; McArthur, J; Bhar, S; Kohorst, M; Bajwa, R; Vatsayan, A; Hingorani, S; Aguayo-Hiraldo, P; polishchuk, V; Sheikh, I ...
Published in: Blood
November 3, 2025
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Blood
DOI
EISSN
1528-0020
ISSN
0006-4971
Publication Date
November 3, 2025
Volume
146
Issue
Supplement 1
Start / End Page
166 / 166
Publisher
American Society of Hematology
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
Citation
APA
Chicago
ICMJE
MLA
NLM
Alqahtani, S., Abdel-Azim, H., McArthur, J., Bhar, S., Kohorst, M., Bajwa, R., … Mahadeo, K. (2025). Prospective registry of pediatric cellular therapy patients at risk for endothelial dysfunction, sinusoidal obstruction syndrome and/or multi-organ dysfunction syndrome(POEM): pmods as a screening tool for endotheliopathies and critical care admission risk in pediatric HCT patients. In Blood (Vol. 146, pp. 166–166). American Society of Hematology. https://doi.org/10.1182/blood-2025-166
Alqahtani, Shaikha, Hisham Abdel-Azim, Jennifer McArthur, Saleh Bhar, Mira Kohorst, Rajinder Bajwa, Anant Vatsayan, et al. “Prospective registry of pediatric cellular therapy patients at risk for endothelial dysfunction, sinusoidal obstruction syndrome and/or multi-organ dysfunction syndrome(POEM): pmods as a screening tool for endotheliopathies and critical care admission risk in pediatric HCT patients.” In Blood, 146:166–166. American Society of Hematology, 2025. https://doi.org/10.1182/blood-2025-166.
Alqahtani S, Abdel-Azim H, McArthur J, Bhar S, Kohorst M, Bajwa R, et al. Prospective registry of pediatric cellular therapy patients at risk for endothelial dysfunction, sinusoidal obstruction syndrome and/or multi-organ dysfunction syndrome(POEM): pmods as a screening tool for endotheliopathies and critical care admission risk in pediatric HCT patients. In: Blood. American Society of Hematology; 2025. p. 166–166.
Alqahtani, Shaikha, et al. “Prospective registry of pediatric cellular therapy patients at risk for endothelial dysfunction, sinusoidal obstruction syndrome and/or multi-organ dysfunction syndrome(POEM): pmods as a screening tool for endotheliopathies and critical care admission risk in pediatric HCT patients.” Blood, vol. 146, no. Supplement 1, American Society of Hematology, 2025, pp. 166–166. Crossref, doi:10.1182/blood-2025-166.
Alqahtani S, Abdel-Azim H, McArthur J, Bhar S, Kohorst M, Bajwa R, Vatsayan A, Hingorani S, Aguayo-Hiraldo P, polishchuk V, Ragoonanan D, Sheikh I, Shoberu B, Spencer L, Schadler K, Mahadeo K. Prospective registry of pediatric cellular therapy patients at risk for endothelial dysfunction, sinusoidal obstruction syndrome and/or multi-organ dysfunction syndrome(POEM): pmods as a screening tool for endotheliopathies and critical care admission risk in pediatric HCT patients. Blood. American Society of Hematology; 2025. p. 166–166.
Published In
Blood
DOI
EISSN
1528-0020
ISSN
0006-4971
Publication Date
November 3, 2025
Volume
146
Issue
Supplement 1
Start / End Page
166 / 166
Publisher
American Society of Hematology
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology